Bariatric surgery improves clinical outcomes and adiposity biomarkers but not inflammatory cytokines SAA and MCP-1 after a six-month follow-up

References

• WHO (World Health Organization). Obesity and overweight. 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
   Google Scholar
• Mun EC, Blackburn GL, Matthews JB. Current status of medical and surgical therapy for obesity. Gastroenterology. 2001;120:669–681.
   PubMed Web of Science ®Google Scholar
• Yanovski SZ, Yanovski JA. Obesity. N Engl J Med. 2002;346:591–602.
   PubMed Web of Science ®Google Scholar
• Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–1737.
   PubMed Web of Science ®Google Scholar
• Welbourn R, Hollyman M, Kinsman R, et al. Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the Fourth IFSO Global Registry Report 2018. Obes Surg. 2019;29:782–795.
   PubMed Web of Science ®Google Scholar
• Cardoso L, Rodrigues D, Gomes L, et al. Short- and long-term mortality after bariatric surgery: a systematic review and meta-analysis. Diabetes Obes Metab. 2017;19:1223–1232.
   PubMed Web of Science ®Google Scholar
• Smith MD, Patterson E, Wahed AS, et al. Thirty-day mortality after bariatric surgery: independently adjudicated causes of death in the longitudinal assessment of bariatric surgery. Obes Surg. 2011;21:1687–1692.
   PubMed Web of Science ®Google Scholar
• Angrisani L, Santonicola A, Iovino P, et al. Bariatric Surgery Worldwide 2013. Obes Surg. 2015;25:1822–1832.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425–432.
   PubMed Web of Science ®Google Scholar
• Frederich RC, Lollmann B, Hamann A, et al. Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J Clin Invest. 1995;96:1658–1663.
   PubMed Web of Science ®Google Scholar
• Mora S, Pessin JE. An adipocentric view of signaling and intracellular trafficking. Diabetes Metab Res Rev. 2002;18:345–356.
   PubMed Web of Science ®Google Scholar
• Yudkin JS, Stehouwer CDA, Emeis JJ, et al. C-reactive protein in healthy subjects: associations with obesity. Arterioscler Thromb Vasc Biol. 1999;19:972–978.
   PubMed Web of Science ®Google Scholar
• Varady KA, Tussing L, Bhutani S, et al. Degree of weight loss required to improve adipokine concentrations and decrease fat cell size in severely obese women. Metabolism. 2009;58:1096–1101.
   PubMed Web of Science ®Google Scholar
• Arner P. Insulin resistance in type 2 diabetes - role of the adipokines. Curr Mol Med. 2005;5:333–339.
   PubMed Web of Science ®Google Scholar
• Davis JF, Choi DL, Schurdak JD, et al. Leptin regulates energy balance and motivation through action at distinct neural circuits. Biol Psychiatry. 2011;69:668–674.
   PubMed Web of Science ®Google Scholar
• Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292–295.
   PubMed Web of Science ®Google Scholar
• Myers MG, Cowley MA, Munzberg H. Mechanisms of leptin action and leptin resistance. Annu Rev Physiol. 2008; 70:537–556.
   PubMed Web of Science ®Google Scholar
• Yadav A, Kataria MA, Saini V, et al. Role of leptin and adiponectin in insulin resistance. Clin Chim Acta. 2013; 417:80–84.
   PubMed Web of Science ®Google Scholar
• Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 1999;100:2473–2476.
   PubMed Web of Science ®Google Scholar
• Ouchi N, Ohishi M, Kihara S, et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension. 2003;42:231–234.
   PubMed Web of Science ®Google Scholar
• Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003;46:459–469.
   PubMed Web of Science ®Google Scholar
• Abdelgadir M, Karlsson AF, Berglund L, et al. Low serum adiponectin concentrations are associated with insulin sensitivity independent of obesity in Sudanese subjects with type 2 diabetes mellitus. Diabetol Metab Syndr. 2013;5:15
   PubMed Web of Science ®Google Scholar
• Das UN. Is obesity an inflammatory condition? Nutrition. 2001;17:953–966.
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860–867.
   PubMed Web of Science ®Google Scholar
• Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796–1808.
   PubMed Web of Science ®Google Scholar
• Matsushima K, Larsen CG, DuBois GC, et al. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med. 1989;169:1485–1490.
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Robinson EA, Tanaka S, et al. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J Exp Med. 1989;169:1449–1459.
   PubMed Web of Science ®Google Scholar
• Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A. 2003;100:7265–7270.
   PubMed Web of Science ®Google Scholar
• Yuasa S, Maruyama T, Yamamoto Y, et al. MCP-1 gene A-2518G polymorphism and carotid artery atherosclerosis in patients with type 2 diabetes. Diabetes Res Clin Pract. 2009;86:193–198.
   PubMed Web of Science ®Google Scholar
• Urieli-Shoval S, Linke RP, Matzner Y. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr Opin Hematol. 2000; 7:64–69.
   PubMed Web of Science ®Google Scholar
• Poitou C, Viguerie N, Cancello R, et al. Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition. Diabetologia. 2005;48:519–528.
   PubMed Web of Science ®Google Scholar
• Jernas M, Palming J, Sjoholm K, et al. Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. Faseb J. 2006;20:1540–1542.
   PubMed Web of Science ®Google Scholar
• Poitou C, Coussieu C, Rouault C, et al. Serum amyloid A: a marker of adiposity-induced low-grade inflammation but not of metabolic status. Obesity. 2006;14:309–318. [Silver Spring].
   PubMed Web of Science ®Google Scholar
• Zhao Y, He X, Shi X, et al. Association between serum amyloid A and obesity: a meta-analysis and systematic review. Inflamm Res. 2010;59:323–334.
   PubMed Web of Science ®Google Scholar
• Hatanaka E, Monteagudo PT, Marrocos MS, et al. Interaction between serum amyloid A and leukocytes – a possible role in the progression of vascular complications in diabetes. Immunol Lett. 2007;108:160–166.
   PubMed Web of Science ®Google Scholar
• Yang RZ, Lee MJ, Hu H, et al. Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Med. 2006;3:e287.
   PubMed Web of Science ®Google Scholar
• Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr. 1992;55:615S–619S.
   PubMed Web of Science ®Google Scholar
• MS. Portaria do Ministério da Saúde n° 424, de 19 de março de 2013. Diretrizes para a organização da prevenção e do tratamento do sobrepeso e obesidade. 2013. Available from: http://bvsms.saude.gov.br/bvs/saudelegis/gm/2013/prt0424_19_03_2013.html
   Google Scholar
• Health NIo. ATP III At-A-Glance: Quick Desk Reference. NHLBI, NIH; 2001. Available from: https://www.ncbi.nlm.nih.gov/pubmed/
   Google Scholar
• Cottam DR, Mattar SG, Barinas-Mitchell E, et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg. 2004;14:589–600.
   PubMed Web of Science ®Google Scholar
• Hatoum IJ, Blackstone R, Hunter TD, et al. Clinical factors associated with remission of obesity-related comorbidities after bariatric surgery. JAMA Surg. 2016;151:130–137.
   PubMed Web of Science ®Google Scholar
• Cremieux PY, Ledoux S, Clerici C, et al. The impact of bariatric surgery on comorbidities and medication use among obese patients. Obes Surg. 2010;20:861–870.
   PubMed Web of Science ®Google Scholar
• Lopes EC, Heineck I, Athaydes G, et al. Is bariatric surgery effective in reducing comorbidities and drug costs? A systematic review and meta-analysis. Obes Surg. 2015;25:1741–1749.
   PubMed Web of Science ®Google Scholar
• Perrone F, Bianciardi E, Benavoli D, et al. Gender influence on long-term weight loss and comorbidities after laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass: a prospective study with a 5-year follow-up. Obes Surg. 2016;26:276–281.
   PubMed Web of Science ®Google Scholar
• Yadav R, Hama S, Liu Y, et al. Effect of Roux-en-Y bariatric surgery on lipoproteins, insulin resistance, and systemic and vascular inflammation in obesity and diabetes. Front Immunol. 2017;8:1512.
   PubMed Web of Science ®Google Scholar
• Khosravi-Largani M, Nojomi M, Aghili R, et al. Evaluation of all types of metabolic bariatric surgery and its consequences: a systematic review and meta-analysis. Obes Surg. 2019;29:651–690.
   PubMed Web of Science ®Google Scholar
• Askarpour M, Alizadeh S, Hadi A, et al. Effect of bariatric surgery on the circulating level of adiponectin, chemerin, plasminogen activator inhibitor-1, leptin, resistin, and visfatin: a systematic review and meta-analysis. Horm Metab Res. 2020;52:207–215.
   PubMed Web of Science ®Google Scholar
• Gomez-Ambrosi J, Salvador J, Rotellar F, et al. Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass. Obes Surg. 2006;16:262–269.
   PubMed Web of Science ®Google Scholar
• Catalan V, Gomez-Ambrosi J, Ramirez B, et al. Pro-inflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass. Obes Surg. 2007;17:1464–1474.
   PubMed Web of Science ®Google Scholar
• Salman MA, Salman AA, Nafea MA, et al. Study of changes of obesity-related inflammatory cytokines after laparoscopic sleeve gastrectomy. ANZ J Surg. 2019;89:1265–1269.
   PubMed Web of Science ®Google Scholar
• Thomsen SB, Rathcke CN, Jorgensen NB, et al. Effects of Roux-en-Y gastric bypass on fasting and postprandial levels of the inflammatory markers YKL-40 and MCP-1 in patients with type 2 diabetes and glucose tolerant subjects. J Obes. 2013; 2013:1–10.
   Google Scholar
• Salman MA, Abdallah A, Mikhail HMS, et al. Long-term impact of mini-gastric bypass on inflammatory cytokines in cohort of morbidly obese patients: a prospective study. Obes Surg. 2020;30:2338–2344.
   PubMed Web of Science ®Google Scholar
• Sams VG, Blackledge C, Wijayatunga N, et al. Effect of bariatric surgery on systemic and adipose tissue inflammation. Surg Endosc. 2016;30:3499–3504.
   PubMed Web of Science ®Google Scholar
• Shimizu H, Hatao F, Imamura K, et al. Early effects of sleeve gastrectomy on obesity-related cytokines and bile acid metabolism in morbidly obese Japanese patients. Obes Surg. 2017;27:3223–3229.
   PubMed Web of Science ®Google Scholar
• Dahlman I, Kaaman M, Olsson T, et al. A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. J Clin Endocrinol Metab. 2005;90:5834–5840.
   PubMed Web of Science ®Google Scholar